Janus Henderson Group PLC Ascendis Pharma A/S Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,186,694 shares of ASND stock, worth $571 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
4,186,694
Previous 3,918,813
6.84%
Holding current value
$571 Million
Previous $534 Million
16.99%
% of portfolio
0.33%
Previous 0.29%
Shares
22 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.32 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$700 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$680 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$602 Million1.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.12MShares$289 Million0.04% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.61B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...